Application of liquid biopsy for prognostic status of cancers and drug response  

在线阅读下载全文

作  者:Dario Marchetti 

机构地区:[1]Division of Molecular Medicine,Department of Internal Medicine,Comprehensive Cancer Center,The University of New Mexico Health Sciences Center,Albuquerque,NM 87131,USA

出  处:《Cancer Drug Resistance》2020年第4期1001-1002,共2页癌症耐药(英文)

摘  要:The vast majority of cancer deaths(>94%)are due to the development of metastatic disease with a considerable fraction of patients experiencing metastatic relapse within five years from primary tumor resection,despite not having any detectable metastasis at that time.Circulating tumor cells(CTCs)are shed from primary/metastatic tumors,circulate in the peripheral vasculature,disseminate to distant tissues,and extravasate by adapting to the new organ microenvironment,followed by tissue colonization generating metastasis.However,the complexities of the metastatic cascade in cancer patients and the elucidation of blood-based mechanisms underlying metastatic onset remain critical challenges.

关 键 词:METASTASIS cancer GENERATING 

分 类 号:R73[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象